Nuveen Large Cap Value Fund Premier (TRCPX)
23.01
+0.19
(+0.83%)
USD |
May 16 2025
Key Stats
Customize
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 0.56% | 6.459B | 1.77% | 19.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| -86.21M | 8.73% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks a favorable long-term total return, mainly through capital appreciation, primarily from equity securities of large domestic companies that appear undervalued by the market. The Fund's benchmark is the Russell 1000 Value Index. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US |
| Peer Group | Large-Cap Value Funds |
| Global Macro | Equity North America |
| US Macro | Large-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Growth & Income Funds |
| Fund Owner Firm Name | Nuveen |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
80
-976.43M
Peer Group Low
699.35M
Peer Group High
1 Year
% Rank:
51
-86.21M
-11.65B
Peer Group Low
7.082B
Peer Group High
3 Months
% Rank:
80
-3.235B
Peer Group Low
3.180B
Peer Group High
3 Years
% Rank:
50
-26.09B
Peer Group Low
10.50B
Peer Group High
6 Months
% Rank:
78
-6.296B
Peer Group Low
3.480B
Peer Group High
5 Years
% Rank:
76
-34.65B
Peer Group Low
11.17B
Peer Group High
YTD
% Rank:
81
-4.177B
Peer Group Low
3.047B
Peer Group High
10 Years
% Rank:
82
-39.59B
Peer Group Low
11.13B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of May 17, 2025.
Asset Allocation
As of February 28, 2025.
| Type | % Net |
|---|---|
| Cash | 0.18% |
| Stock | 99.82% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.00% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| JPMorgan Chase & Co | 3.90% | 267.56 | 0.03% |
| UnitedHealth Group Inc | 2.96% | 291.91 | 6.40% |
| Exxon Mobil Corp | 2.93% | 108.19 | -0.36% |
| Berkshire Hathaway Inc | 2.93% | 514.31 | 1.38% |
| Johnson & Johnson | 2.31% | 151.33 | 1.15% |
| Wells Fargo & Co | 2.24% | 76.18 | 0.78% |
| Bank of America Corp | 2.23% | 44.69 | 0.70% |
| Walmart Inc | 2.01% | 98.24 | 1.96% |
| RTX Corp | 1.99% | 135.48 | -0.03% |
| Abbott Laboratories | 1.96% | 134.80 | 1.09% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | 0.15% |
| Actual Management Fee | 0.40% |
| Administration Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | 0.00% |
| General Availability | |
| Available for Insurance Product | -- |
| Available for RRSP | -- |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 0.00 None |
| Minimum Subsequent Investment | 0.00 None |
Basic Info
| Investment Strategy | |
| The Fund seeks a favorable long-term total return, mainly through capital appreciation, primarily from equity securities of large domestic companies that appear undervalued by the market. The Fund's benchmark is the Russell 1000 Value Index. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US |
| Peer Group | Large-Cap Value Funds |
| Global Macro | Equity North America |
| US Macro | Large-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Growth & Income Funds |
| Fund Owner Firm Name | Nuveen |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (5-16-25) | 1.28% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Stock | |
| Weighted Average PE Ratio | 25.53 |
| Weighted Average Price to Sales Ratio | 4.278 |
| Weighted Average Price to Book Ratio | 4.856 |
| Weighted Median ROE | 61.29% |
| Weighted Median ROA | 6.98% |
| ROI (TTM) | 12.62% |
| Return on Investment (TTM) | 12.62% |
| Earning Yield | 0.0475 |
| LT Debt / Shareholders Equity | 1.839 |
As of February 28, 2025
Growth Metrics
| EPS Growth (1Y) | 14.48% |
| EPS Growth (3Y) | 6.89% |
| EPS Growth (5Y) | 10.11% |
| Sales Growth (1Y) | 5.45% |
| Sales Growth (3Y) | 6.80% |
| Sales Growth (5Y) | 6.73% |
| Sales per Share Growth (1Y) | 11.19% |
| Sales per Share Growth (3Y) | 8.68% |
| Operating Cash Flow - Growth Ratge (3Y) | 4.70% |
As of February 28, 2025
Fund Details
| Key Dates | |
| Inception Date | 10/1/2002 |
| Last Annual Report Date | 10/31/2024 |
| Last Prospectus Date | 3/1/2025 |
| Share Classes | |
| TCLCX | A |
| TRLCX | Retirement |
| TRLHX | Inst |
| TRLIX | Retirement |
| TRLWX | Other |
| Attributes | |
| Index Fund | -- |
| Inverse Fund | -- |
| Leveraged Fund | -- |
| Fund of Funds | No |
| Currency Hedged Fund | -- |
| Synthetic Replication Fund | No |
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:TRCPX", "name") |
| Broad Asset Class: =YCI("M:TRCPX", "broad_asset_class") |
| Broad Category: =YCI("M:TRCPX", "broad_category_group") |
| Prospectus Objective: =YCI("M:TRCPX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |